EVIO announced its expansion into the California market thanks to a purchase agreement for the acquisition of testing lab Leaf Detective.

EVIO (OTCQB:EVIO) announced its expansion into the California market thanks to a purchase agreement for the acquisition of testing lab Leaf Detective.

As quoted in the press release:

Leaf Detective, Humboldt County’s first licensed cannabis testing facility, is an independently owned and operated testing facility dedicated to providing accurate results in a timely manner. The lab specializes in analytical laboratory testing for medical marijuana dispensaries, cannabis manufacturers, producers and consumers.

Due to California’s July 1 testing deadline mandating licensed retailers to sell only lab tested product, the industry is predicting a shortage of testing services and delays in getting approval to sell the products. This strategic acquisition is part of EVIO’s efforts to further expand into the state to meet increasing demand for analytical testing services.

“Leaf Detective holds one of only 28 licenses issued by the Bureau of Cannabis Control to testing facilities. Upon completion of this acquisition, we will upgrade the facility to meet new testing standards and plan to be operational by end of third quarter,” said William Waldrop, CEO of EVIO Inc. “Our goal is to continue to improve consumer safety and increase shareholder value by capturing additional market share.”

Click here to read the full press release.

Source: globenewswire.com

Featured
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofCronos Group Inc. for violations of the securities lawsThe investigation focuses on whether the Company issued false andor misleading statements andor failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9, 2021, disclosing that the ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofCronos Group Inc. ("Cronos" or "the Company") (NASDAQ:CRON) for violations of the securities laws

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9, 2021, disclosing that the Company would "be required to restate its previously issued unaudited interim financial statements for the three and six months ended June 30, 2021" and that "the Company's financial statements for this period should therefore no longer be relied upon." Based on this news, shares of Cronos fell by nearly 16%.

read more Show less
The company's first ESG report outlines efforts to operate with integrity and support long-term sustainability Trulieve Cannabis Corp. the largest multi-state operator in the United States today announced the publication of its first Environmental, Social, and Governance Report . The Report contains standard disclosures from the Global Reporting Initiative Sustainability Reporting Standards, The Sustainability ...

The company's first ESG report outlines efforts to operate with integrity and support
long-term sustainability

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), the largest multi-state operator (MSO) in the United States today announced the publication of its first Environmental, Social, and Governance (ESG) Report (the "Report"). The Report contains standard disclosures from the Global Reporting Initiative (GRI) Sustainability Reporting Standards, The Sustainability Accounting Standards Board (SASB) as well as the United Nations Sustainable Development Goals. The Report highlights ESG achievements to date and serves as a foundation for demonstrating how the Company's ESG approach, strategies and commitments are embedded within its core business.

read more Show less
Pomerantz LLP is investigating claims on behalf of investors of Cronos Group Inc. . Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Cronos and certain of its officers andor directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On ...

Pomerantz LLP is investigating claims on behalf of investors of Cronos Group Inc. ("Cronos" or the "Company") (NASDAQ: CRON). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Cronos and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

read more Show less

MARKETS

Markets
TSX21149.00+23.10
TSXV954.26+10.21
DOW35135.94+236.60
S&P 5004655.27+60.65
NASD15782.83+291.18
ASX7239.80-39.50

COMMODITIES

Commodities
Gold1792.95+6.33
Silver22.93+0.01
Copper4.32-0.03
Palladium1797.00+8.08
Platinum965.00-0.99
Oil68.63-1.32
Heating Oil2.11-0.04
Natural Gas4.76-0.09